Glossary of Psilocybin and Harm Reduction Terms
Education only. This page is for harm reduction education. It is not medical advice and does not encourage psilocybin use. Psilocybin is illegal in most places — see legal status.
Plain-language summary
This page explains common words used when people talk about psilocybin and staying safe. Each term gets a short, plain definition. Use it as a quick reference while reading the rest of the site. When a word links to another page, you can click through to learn more.
The mushroom and its chemistry
- Psilocybin
- The main mind-altering compound in "magic" mushrooms. By itself it does nothing; the body turns it into psilocin, which causes the effects.[1] Learn more on what is psilocybin.
- Psilocin
- The active form of psilocybin. Once psilocybin breaks down into psilocin, it acts on serotonin receptors in the brain to cause the trip.[1]
- Psilocybe
- The scientific name for the main group of mushrooms that contain psilocybin. Many unrelated mushrooms look similar but are not psilocybin mushrooms — some are poisonous.
- Alkaloid
- A natural compound made by some plants and fungi that affects the body. Psilocybin and psilocin are alkaloids.
- Baeocystin and norbaeocystin
- Minor compounds found alongside psilocybin in some mushrooms. Their effects in people are not well understood.
How it works in the brain
- Serotonin
- A chemical messenger in the brain and body that helps steady mood, sleep, and the senses. Psilocin's effects come from acting on serotonin systems.[1]
- 5-HT2A receptor
- A specific docking site for serotonin on brain cells. Psilocin switches this receptor on, which is thought to cause the main trip effects.[1]
- Agonist
- A substance that turns a receptor on, the way a key turns a lock. Psilocin is an agonist at the 5-HT2A receptor.
- Half-life
- The time it takes for the body to clear half of a substance. Psilocin has a short half-life, which is one reason a psilocybin trip usually lasts about four to six hours.[1]
- Neuroplasticity
- The brain's ability to form new links and change over time. Some studies ask whether psychedelics affect it, but the findings are early and not settled.
The experience
- Trip
- Everyday word for the altered state caused by a psychedelic — changes in senses, thoughts, emotions, and sense of time.
- Dose-response
- The idea that effects change with the amount taken. With psilocybin, bigger doses tend to bring stronger effects and a higher chance of a hard trip.[2]
- Come-up
- The early part of a trip when effects are starting to build, usually within the first hour after eating mushrooms.
- Peak
- The strongest part of the experience, when effects are most intense.
- Comedown
- The later part of the trip when effects fade and the person returns to normal. People often feel tired or reflective.
- Ego dissolution
- A state, usually at higher doses, where the normal sense of being a separate "self" fades or disappears. It can feel freeing or frightening.[2]
- Challenging experience
- A neutral term for a "bad trip" — a spell of fear, worry, or distress during the effects. It is common and usually passes with calm support.[3] See difficult experiences.
- Synesthesia
- A mixing of the senses, such as "seeing" sounds or "hearing" colors. Some people report this during a trip.
Safety and harm reduction
- Harm reduction
- A down-to-earth approach that aims to lower the risks of an act for people who may do it anyway, instead of only saying "don't." This whole site is built on it.
- Set and setting
- "Set" is your mindset — mood and expectations. "Setting" is your surroundings. Both strongly shape how an experience goes.[2] See set and setting.
- Trip sitter
- A sober, trusted person who stays with someone during a trip to keep them safe and calm. See trip sitting.
- Tolerance
- When the body responds less to the same dose after recent use. Psilocybin tolerance builds quickly and fades over one to two weeks.[1] See tolerance.
- Cross-tolerance
- When tolerance to one drug lowers the effect of a similar drug. Psilocybin and LSD show cross-tolerance because they act on the same receptor.[1]
- Contraindication
- A health reason someone should avoid a drug. For psilocybin, examples include a personal or family history of psychosis and some heart conditions.[2] See risks.
- Drug interaction
- When two substances change each other's effects or raise risk when combined. See drug interactions.
- Serotonin syndrome
- A dangerous state from too much serotonin activity, often caused by mixing serotonin-affecting drugs. Signs include high fever, stiff muscles, and a racing heart. It is a medical emergency.[2]
- HPPD (hallucinogen persisting perception disorder)
- A rare condition where trip-like visual changes keep coming back long after the drug has worn off.[4] See HPPD.
- Flashback
- A brief, unexpected return of a trip-like feeling or visual after the experience is over. Unlike HPPD, flashbacks are occasional rather than constant.[4]
- Microdosing
- Taking a dose too small to cause a noticeable trip, often a few times a week. Its benefits and long-term safety are not proven.[2] See myths and facts.
- Body load
- Physical discomfort during a trip, such as nausea, yawning, chills, or muscle tension. It often eases after the come-up.
- Misidentification
- Mistaking a poisonous mushroom for a psilocybin one. This is a leading cause of serious mushroom poisoning. See emergencies.
Law and research
- Schedule I
- The strictest US drug group, for drugs treated as easy to abuse and having no accepted medical use. Psilocybin is Schedule I under federal law.[1] See legal status.
- Decriminalization
- Reducing or removing criminal penalties for something, without making it fully legal. Some US places have decriminalized psilocybin, but it remains illegal under federal law.
- Placebo
- A dummy treatment with no active drug, used in studies to see how much of an effect comes from expectation. Microdosing trials rely on it heavily.[2]
- Clinical trial
- A carefully run study in people, with screening, dosing, and close watching, used to test whether a treatment is safe and works.[3] See clinical research.
Need help right now?
- Medical emergency (US): call 911.
- Poison Control (US): 1-800-222-1222 — free, confidential, 24/7.
- Fireside Project (psychedelic peer support line, US): call or text 62-FIRESIDE (623-473-7433).
- 988 Suicide & Crisis Lifeline (US): call or text 988.
References
- Nichols DE. Psychedelics. Pharmacological Reviews. 2016;68(2):264-355.
- Johnson MW, Richards WA, Griffiths RR. Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology. 2008;22(6):603-620.
- Carbonaro TM, Bradstreet MP, Barrett FS, et al. Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences. Journal of Psychopharmacology. 2016;30(12):1268-1278.
- Halpern JH, Pope HG Jr. Hallucinogen persisting perception disorder: what do we know after 50 years? Drug and Alcohol Dependence. 2003;69(2):109-119.